Sandu Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

64.00 -0.75 ▼-1.2%

08 February 2023, 09:30:00 AM
Volume: 345

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sandu.in
Market Cap 57.05 Cr.
Enterprise Value(EV) 50.94 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.69 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 38.34 Trailing Twelve Months Ending 2022-09
Industry PE 32.80 Trailing Twelve Months Ending 2022-09
Book Value / Share 32.22 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.01 Calculated using Price: 64.75
Dividend Yield 1.16 Period Ending 2022-03
No. of Shares Subscribed 0.88 Cr. 8,810,664 Shares
FaceValue 10
Company Profile
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.16%
1 Week
-0.93%
1 Month
+1.43%
3 Month
+2.32%
6 Month
-2.74%
1 Year
+3.23%
2 Year
+98.45%
5 Year
+63.27%
10 Year
+316.94%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.76 2.28 2.92 -2.44 3.09 3.53 3.66 5.03 6.29
Return on Capital Employed (%) 6.93 6.80 7.65 5.30 7.06 7.58 5.79 7.87 9.35
Return on Assets (%) 1.41 1.06 1.30 -1.01 1.23 1.52 1.69 2.47 3.30

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 18 18 19 27 28 29 29 33 36 38
Non Curr. Liab. 3 2 2 1 1 1 1 1 1 1
Curr. Liab. 16 21 21 18 15 14 11 13 12 13
Minority Int.
Equity & Liab. 37 42 41 46 45 44 41 47 49 52
Non Curr. Assets 10 9 9 18 24 24 19 16 26 26
Curr. Assets 27 32 33 28 21 20 22 31 24 26
Misc. Exp. not W/O
Total Assets 37 42 41 46 45 44 41 47 49 52

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 36 40 41 43 49 49 48 59 66 64
Other Income 0 0 0 0 0 1 0 0 0 0
Total Income 36 40 41 43 49 50 49 59 66 64
Total Expenditure -34 -37 -38 -41 -47 -47 -47 -57 -63 -61
PBIDT 2 3 3 2 3 3 2 2 3 3
Interest -1 -1 -2 -1 -1 -1 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 -1 0 0 0 -1 -1 -1
Exceptional Items 0
PAT 1 0 1 0 1 1 1 1 2 1
Adjusted EPS 1 1 1 -1 1 1 1 1 2 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 -1 5 -1 5 1 4 6 8 1
Cash Fr. Inv. -2 -1 0 0 -1 -1 0 0 -6 -5
Cash Fr. Finan. 0 0 -2 -2 -2 -2 -4 -5 1 1
Net Change 3 -2 3 -3 2 -1 -1 0 3 -4
Cash & Cash Eqvt 3 1 4 1 3 1 1 1 5 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 45.04 45.04 45.04 45.04 48.02 50.43 50.43 49.47 49.47
Public 54.96 54.96 54.96 54.96 51.98 49.57 49.57 50.53 50.53
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Stop Transfer for Duplicate issue of share Certificate KAUSHIK J SHAH
Fri, 03 Feb 2023
Board Meeting Intimation for Unaudited Financial Results For Q Ended 31St December 2022
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Unaudited Financial Results for Q ended 31st December 2022
Tue, 31 Jan 2023
Listing Approval For 03Rd Trench Of Equity Shares On BSE
Listing Approval for 03rd Trench of Equity Shares on BSE

Technical Scans View Details >>

Tue, 07 Feb 2023
High Delivery Percentage High Delivery Percentage
High Increase in 2 Years High Increase in 2 Years
Closing Near 50 SMA Closing Near 50 SMA
Mon, 06 Feb 2023
High Delivery Percentage High Delivery Percentage
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,000.90 -0.6%
Cipla Ltd. 83,244.79 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,450.00 +0.2%
Divi's Laboratories Ltd. 72,982.62 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. 51,953.07 1,537.15 +0.1%
Zydus Lifesciences Ltd. 48,525.07 477.40 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,000.90 -0.6%
Cipla Ltd. Consolidated 2022-12 31.56 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,537.15 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 477.40 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,000.90 -0.6%
Cipla Ltd. Consolidated 2022-12 3.67 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,537.15 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 477.40 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,000.90 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.15 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.40 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,000.90 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.15 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.40 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,000.90 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.15 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.40 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,000.90 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.15 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.40 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,000.90 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,025.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,767.65 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,324.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.15 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.40 -0.4%

FAQ's On Sandu Pharmaceuticals Ltd.

What is Sandu Pharmaceutical share price?
Can I buy Sandu Pharmaceutical shares now?
What is the Dividend Yield of Sandu Pharmaceutical?
What is the Market Cap of Sandu Pharmaceutical?
What are the key metrics to analyse Sandu Pharmaceutical?
What is the 52 Week High and Low of Sandu Pharmaceutical?
What is the trend of Sandu Pharmaceutical share price?